Authors
Latest:
Your Company Receives a Subpoena – What Now?With the growth of civil and criminal litigation, more companies in the health care space are receiving subpoenas commanding them to provide information to a third party.
Latest:
ASCO 2025: Stratifying NSCLC Treatment by HER2-Alteration SubtypeNikita Dahake, MD; Hossein Borghaei, DO, MS; and Yasmine Baca, MS, PhD candidate, MB(ASCP)CM, explore how distinct HER2-alteration subtypes in non-small cell lung cancer (NSCLC) impact survival outcomes, co-mutation profiles, and treatment response to immunotherapy-based regimens.
Latest:
Pharmacy Care Coaches Improve Outcomes in Patients With DiabetesCare Coach program offers a comprehensive set of pharmacy and counseling services to patients struggling to manage their diabetes.
Latest:
Combat Methamphetamine Epidemic Act of 2005 Takes Aim at Drug CrisisCurtailing the availability of meth precursors in the principal focus of the law, paving the way for states to follow suit.
Latest:
The Impact of COVID-19 on Cervical, Breast Cancer ScreeningsBreast cancer screening guidelines using mammography vary among guiding bodies, including the American Cancer Society and the American Academy of Family Physicians.
Latest:
From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCLBV-R2 combination shows survival benefit across high-risk subgroups.
Latest:
How to Use Data to Transform Pharmacy PracticeTips to help community-based pharmacists use the data at their fingertips to better market and provide the enhanced pharmacy services that drive practice transformation.
Latest:
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular CareFrank Qian, MD, MPH, discusses the integration of omega-3 fatty acid therapy alongside statins and PCSK9 inhibitors in cardiovascular risk management, highlighting the distinct mechanisms of benefit and lack of significant drug interactions.
Latest:
ASCO 2025: How AI-Powered Tools Are Reshaping Oncology Data Capture and Clinical Decision-MakingGayathri Namasivayam, PhD, discusses how large language models are being used to extract structured oncology data from unstructured electronic health records to improve clinical efficiency, support real-world evidence generation, and enhance oncology pharmacy workflows.
Latest:
Strategic AI Budgeting for Pharmacies in 2025Pharmacies can strategically invest in AI technologies to streamline operations and improve patient care while addressing cost challenges and maximizing return on investment in 2025.
Latest:
COVID-19 Booster Shots and the FutureKey opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Latest:
Pharmacists Are in Key Positions to Tackle Black Maternal Mortality DisparitiesTackling racial disparities among health care providers can help improve disparities faced by patients.
Latest:
Help Patients Use Inhalers ProperlyChoosing the appropriate device and using the correct technique are critical for drug delivery to the lungs.
Latest:
Evaluation of Antibiotic Administration Surrounding Interventional Radiology ProceduresImplementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.
Latest:
Clinical Overview: 2023-2024 COVID-19 VaccinesAn overview of updated CDC ACIP recommendations for COVID-19 vaccines available through commercial channels for the 2023-2024 season.
Latest:
Exploring the Landscape of Gene TherapyAn overview of how gene therapy has evolved since its inception, current applications, and emerging challenges.
Latest:
Considerations for RSV Vaccination During PregnancyExplore the latest advancements in RSV vaccination strategies for newborns, focusing on maternal immunization and post-birth protection options.
Latest:
Direct Oral Anticoagulant Use for Left Ventricular Thrombus TreatmentAn overview of the use of direct oral anticoagulants as an alternative to warfarin in the treatment of left ventricular thrombus.
Latest:
ADA 2025: Bridging Gaps in Diabetes Management and Patient CareExpert shares insights on advancing diabetes care in community pharmacies.
Latest:
Use of PD-1/PD-L1 and VEGF Inhibition Combination Is ExpandingThe relatively new combination of PD-1/PD-L1 inhibitors with VEGF inhibitors represents a promising option for patients with various malignancies.
Latest:
Expert: Alcohol Dependence Is an Epidemic, Yet Treatments ExistPharmacists play an important role in the recovery journey for patients who decide medication assisted treatment is right for them.
Latest:
Op-Ed: Nontraditional Pharmacy Career Paths Continue to Gain TractionPharmacy benefit managers offer mentorship, training opportunities, and professional advancement beyond what's available in traditional pharmacy careers.
Latest:
Has C. difficile Met Its Match?Living organisms rely on iron for survival and replication. Can new research discoveries disrupt C. difficile’s ability to maintain iron homeostasis?
Latest:
Essential Hospitals Can Redirect 2025 Medicare Part D Cap Funds to Serve Disadvantaged Patients, CommunitiesTo make the best use of these funds to improve a hospital’s services, leaders should start planning now for these changes using the 4 following strategies.
Latest:
How the Decentralization of Clinical Trials Can Transform Health CareDecentralization has already been shown to streamline clinical trials, but it also has the potential to improve the broader health care ecosystem.
Latest:
The Promise of Psilocybin-Assisted Therapy for Opioid Use DisorderWith Oregon, Colorado, and New Mexico legalizing psilocybin-assisted therapy, opportunities for treatment are expanding.
Latest:
Updates in the First-Line Treatment of Advanced Renal Cell CarcinomaCurrent guideline recommendations include various combinations of targeted therapy with immunotherapy.
Latest:
Additional Considerations With PBC TherapiesPanelists discuss how recent FDA regulatory actions regarding obeticholic acid have raised concerns about its long-term safety profile and accessibility, leading health care teams to develop strategies for supporting patients through treatment transitions while navigating insurance coverage and access challenges for newer primary biliary cholangitis (PBC) therapies.
Latest:
Deprescribing Benzodiazepines in Older Adults: An Anesthesiology Quality InitiativeA novel collaboration between the University of Pennsylvania and US Anesthesia Partners is working to drive evidence-based change in benzodiazepine use.
